A

Abingworth Portfolio holdings

AUM $307M
This Quarter Return
+49.77%
1 Year Return
+93.6%
3 Year Return
+207.29%
5 Year Return
+452.78%
10 Year Return
–
AUM
$161M
AUM Growth
+$161M
Cap. Flow
-$15.1M
Cap. Flow %
-9.4%
Top 10 Hldgs %
93.66%
Holding
18
New
1
Increased
–
Reduced
2
Closed
2

Top Buys

1
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
$2.98M

Top Sells

1
CBAY
Cymabay Therapeutics
CBAY
$11.3M
2
CASC
Cascadian Therapeutics, Inc.
CASC
$3.42M
3
CRSP icon
CRISPR Therapeutics
CRSP
$2.93M
4
EVAR
Lombard Medical, Inc.
EVAR
$399K

Sector Composition

1 Healthcare 98.94%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
CRSP icon
1
CRISPR Therapeutics
CRSP
$4.71B
$86.2M 53.59% 1,887,202 -64,157 -3% -$2.93M
SIEN
2
DELISTED
Sientra, Inc.
SIEN
$21.2M 13.19% 2,199,012 – –
PRTK
3
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$13.5M 8.41% 1,041,131 – –
ONCT
4
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$6.02M 3.74% 339,174 – –
OBSV
5
DELISTED
ObsEva SA Ordinary Shares
OBSV
$5.84M 3.63% 440,000 – –
TARA icon
6
Protara Therapeutics
TARA
$120M
$5.05M 3.14% 2,017,872 – –
CBAY
7
DELISTED
Cymabay Therapeutics
CBAY
$3.55M 2.21% 273,417 -873,660 -76% -$11.3M
CLLS
8
Cellectis
CLLS
$258M
$3.15M 1.96% 100,000 – –
CHMA
9
DELISTED
Chiasma, Inc. Common Stock
CHMA
$3.12M 1.94% 2,080,595 – –
SRRA
10
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$2.98M 1.85% +1,444,445 New +$2.98M
ADAP
11
Adaptimmune Therapeutics
ADAP
$15.6M
$2.81M 1.74% 250,000 – –
OCGN icon
12
Ocugen
OCGN
$319M
$2.44M 1.52% 888,889 – –
RARE icon
13
Ultragenyx Pharmaceutical
RARE
$2.89B
$1.94M 1.21% 38,100 – –
AUPH icon
14
Aurinia Pharmaceuticals
AUPH
$1.58B
$1.31M 0.81% 252,129 – –
IMDZ
15
DELISTED
Immune Design Corp.
IMDZ
$1.15M 0.71% 352,300 – –
DERM
16
DELISTED
Dermira, Inc.
DERM
$559K 0.35% 70,000 – –
CASC
17
DELISTED
Cascadian Therapeutics, Inc.
CASC
– – -925,000 Closed -$3.42M
EVAR
18
DELISTED
Lombard Medical, Inc.
EVAR
– – -3,473,452 Closed -$399K